104 related articles for article (PubMed ID: 23289836)
41. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Basu S; Alavi A
Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
[No Abstract] [Full Text] [Related]
42. FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid.
Wissmeyer M; Weidner S; Muggli B; Weimann R; Juengling FD; Krause T
Clin Nucl Med; 2007 May; 32(5):383-7. PubMed ID: 17452869
[No Abstract] [Full Text] [Related]
43. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
44. [Early detection of synchronous thyroid carcinoma and malignant melanoma by fluorodeoxyglucose positron emission tomography].
Snen M; Decker G; Lasar Y; Pilloy W; Berchem G
Bull Soc Sci Med Grand Duche Luxemb; 2003; (2):111-5. PubMed ID: 15544005
[TBL] [Abstract][Full Text] [Related]
45. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
Hagenimana N; Dallaire J; Vallée É; Belzile M
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
[TBL] [Abstract][Full Text] [Related]
46. Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Aide N; Bardet S
J Nucl Med; 2007 Sep; 48(9):1574; author reply 1574-5. PubMed ID: 17785732
[No Abstract] [Full Text] [Related]
47. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Ciarallo A; Marcus C; Taghipour M; Subramaniam RM
PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091
[TBL] [Abstract][Full Text] [Related]
48. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
Kim CE; Joyce JM; Patel N; Lichter J
Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Yang Z; Shi W; Zhu B; Hu S; Zhang Y; Wang M; Zhang J; Yao Z; Zhang Y
J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):327-33. PubMed ID: 23092835
[TBL] [Abstract][Full Text] [Related]
50. 18F-FDG PET of thyroid nodules with inconclusive cytologic results.
Martínez-Duncker C; Hurtado-López LM
J Nucl Med; 2006 Sep; 47(9):1555; author reply 1555-6. PubMed ID: 16954566
[No Abstract] [Full Text] [Related]
51. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
52. [Annex V: 18-fluorodeoxyglucose positron emission tomography in the management of differentiated thyroid cancers].
Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S90-3. PubMed ID: 18342286
[No Abstract] [Full Text] [Related]
53. Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Jackson RT; Sinha P; Conrad GR
Clin Nucl Med; 2008 Jul; 33(7):505-6. PubMed ID: 18580244
[TBL] [Abstract][Full Text] [Related]
54. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Kim H; Kim SJ; Kim IJ; Kim K
Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
56. Response of calcitonin levels due to positron emission tomography with (18)F-FDG.
Strauss LG; Frangos S; Dimitrakopoulou-Strauss A
Hell J Nucl Med; 2012; 15(3):251. PubMed ID: 23227461
[No Abstract] [Full Text] [Related]
57. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
58. Incidental hot spot in the oesophagus on positron-emission tomography/computed tomography imaging.
Sato R; Muto S
Eur Heart J; 2021 Jul; 42(25):2511. PubMed ID: 32944738
[No Abstract] [Full Text] [Related]
59. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
[No Abstract] [Full Text] [Related]
60. Clinical significance of patterns of increased [
Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
